Product Code: ETC13334629 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe Neoantigen Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Neoantigen Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Neoantigen Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Neoantigen Market - Industry Life Cycle |
3.4 Europe Neoantigen Market - Porter's Five Forces |
3.5 Europe Neoantigen Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Neoantigen Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Europe Neoantigen Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Europe Neoantigen Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Europe Neoantigen Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Europe Neoantigen Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Neoantigen Market Trends |
6 Europe Neoantigen Market, 2021 - 2031 |
6.1 Europe Neoantigen Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe Neoantigen Market, Revenues & Volume, By Personalized Neoantigens, 2021 - 2031 |
6.1.3 Europe Neoantigen Market, Revenues & Volume, By Shared Neoantigens, 2021 - 2031 |
6.2 Europe Neoantigen Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe Neoantigen Market, Revenues & Volume, By DNA Sequencing, 2021 - 2031 |
6.2.3 Europe Neoantigen Market, Revenues & Volume, By RNA Sequencing, 2021 - 2031 |
6.2.4 Europe Neoantigen Market, Revenues & Volume, By Mass Spectrometry, 2021 - 2031 |
6.3 Europe Neoantigen Market, Revenues & Volume, By Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe Neoantigen Market, Revenues & Volume, By Cancer Immunotherapy, 2021 - 2031 |
6.3.3 Europe Neoantigen Market, Revenues & Volume, By Vaccine Development, 2021 - 2031 |
6.3.4 Europe Neoantigen Market, Revenues & Volume, By Drug Discovery, 2021 - 2031 |
6.4 Europe Neoantigen Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Europe Neoantigen Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Europe Neoantigen Market, Revenues & Volume, By Research Institutes, 2021 - 2031 |
6.4.4 Europe Neoantigen Market, Revenues & Volume, By Biotechnology Companies, 2020 - 2028 |
7 Europe Neoantigen Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe Neoantigen Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 United Kingdom (UK) Neoantigen Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 Germany Neoantigen Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 France Neoantigen Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.4 Poland Neoantigen Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.5 Spain Neoantigen Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.6 Rest of Europe Neoantigen Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 Europe Neoantigen Market Revenues & Volume Share, By Technology, 2021 & 2031F |
7.3.1 United Kingdom (UK) Neoantigen Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.2 Germany Neoantigen Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.3 France Neoantigen Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.4 Poland Neoantigen Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.5 Spain Neoantigen Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.6 Rest of Europe Neoantigen Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4 Europe Neoantigen Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.1 United Kingdom (UK) Neoantigen Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.2 Germany Neoantigen Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.3 France Neoantigen Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.4 Poland Neoantigen Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.5 Spain Neoantigen Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.6 Rest of Europe Neoantigen Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 Europe Neoantigen Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.1 United Kingdom (UK) Neoantigen Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.2 Germany Neoantigen Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.3 France Neoantigen Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.4 Poland Neoantigen Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.5 Spain Neoantigen Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.6 Rest of Europe Neoantigen Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Europe Neoantigen Market Key Performance Indicators |
9 Europe Neoantigen Market - Export/Import By Countries Assessment |
10 Europe Neoantigen Market - Opportunity Assessment |
10.1 Europe Neoantigen Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe Neoantigen Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 Europe Neoantigen Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.4 Europe Neoantigen Market Opportunity Assessment, By Application, 2021 & 2031F |
10.5 Europe Neoantigen Market Opportunity Assessment, By End User, 2021 & 2031F |
11 Europe Neoantigen Market - Competitive Landscape |
11.1 Europe Neoantigen Market Revenue Share, By Companies, 2022 |
11.2 Europe Neoantigen Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |